MediciNovaMNOV
Market Cap: $82.9M
About: MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
Employees: 13
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
100% more call options, than puts
Call options by funds: $10K | Put options by funds: $5K
4% more capital invested
Capital invested by funds: $6.78M [Q1] → $7.04M (+$260K) [Q2]
0.23% more ownership
Funds ownership: 9.53% [Q1] → 9.76% (+0.23%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
6% less funds holding
Funds holding: 35 [Q1] → 33 (-2) [Q2]
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
87% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 15
Research analyst outlook
We haven’t received any recent analyst ratings for MNOV.
Financial journalist opinion
Based on 3 articles about MNOV published over the past 30 days